Results 11 to 20 of about 1,616 (183)

Akt inhibitor deguelin aggravates inflammation and fibrosis in myocarditis [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2019
Objective(s): Myocarditis is characterized by inflammatory cell infiltration in myocardial stroma. Attenuation of tumor necrosis factor (TNF)-α and interleukin (IL)-1β is a reliable mark for improving the prognosis.
Shanshan Li   +10 more
doaj   +3 more sources

Deguelin attenuates reperfusion injury and improves outcome after orthotopic lung transplantation in the rat. [PDF]

open access: yesPLoS ONE, 2012
The main goal of adequate organ preservation is to avoid further cellular metabolism during the phase of ischemia. However, modern preservation solutions do rarely achieve this target.
Patrick Paulus   +8 more
doaj   +5 more sources

Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis [PDF]

open access: yesCell Death and Disease
Radioresistance is a major constraint on the efficacy of lung cancer radiotherapy, but its mechanism has not been fully elucidated. Here, we found that FBXO22 was aberrantly highly expressed in lung cancer and that FBXO22 knockdown increased the ...
Yunshang Chen   +12 more
doaj   +2 more sources

The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts [PDF]

open access: yesViruses, 2018
Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus for which there is no vaccine or cure. This viral infection, once acquired, is life-long, residing latently in hematopoietic cells.
Masatoshi Nukui   +2 more
doaj   +3 more sources

Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation [PDF]

open access: yesCell Death and Disease
Cutaneous squamous carcinoma is the second most common epithelial malignancy, associated with significant morbidity, mortality, and economic burden. However, the mechanisms underlying cSCC remain poorly understood.
Kaili Zhou   +10 more
doaj   +2 more sources

Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on “The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts” [PDF]

open access: yesViruses, 2019
Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that establishes a lifelong persistence in the host through both chronic and latent states of infection [...]
Beatrice Mercorelli   +4 more
doaj   +3 more sources

Deguelin Attenuates Non-Small-Cell Lung Cancer Cell Metastasis by Upregulating PTEN/KLF4/EMT Signaling Pathway. [PDF]

open access: yesDis Markers, 2022
Non‐small‐cell lung cancer (NSCLC) is the most common lung cancer and a major cause of cancer mortality worldwide. Deguelin plays a vital inhibitory role in NSCLC initiation and development. However, the downstream mechanism of deguelin‐suppressed metastasis of NSCLC cells is still not completely understood.
Lu G, Yao Y, Zhang X, Cui D, Zhou J.
europepmc   +2 more sources

Novel insights into immunopathogenesis and crucial biomarkers between primary open-angle glaucoma and systemic lupus erythematosus. [PDF]

open access: yesIMetaOmics
This study revealed a novel correlation between systemic lupus erythematosus (SLE) and primary open‐angle glaucoma (POAG) through comprehensive bioinformatics analysis and experimentation, identifying biomarkers and immunopathogenesis for future research and treatment of SLE‐related POAG.
Liu Y   +5 more
europepmc   +2 more sources

BAD, a Proapoptotic Protein, Escapes ERK/RSK Phosphorylation in Deguelin and siRNA-Treated HeLa Cells. [PDF]

open access: yesPLoS ONE, 2016
This study has been undertaken to explore the therapeutic effects of deguelin and specific siRNAs in HeLa cells. The data provided clearly show the silencing of ERK 1/2 with siRNAs and inhibition of ERK1/2 with deguelin treatment in HeLa cells ...
Samra Hafeez   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy